The genetic versus pharmacological invalidation of the cannabinoid CB1 receptor results in differential effects on 'non-associative' memory and forebrain monoamine concentrations in mice

Neurobiology of Learning and Memory

Volumn 88, Issue 4, 2007, Pages 416-423

  Thiemann, Gunnar ^a   Ledent, Catherine ^b  

^a C)   (United Kingdom)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Biogenic amines; CB1 knockout; Habituation; Hippocampus; Rimonabant

Indexed keywords

BRAIN MONOAMINE; CANNABINOID 1 RECEPTOR; DOPAMINE; RIMONABANT; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG MECHANISM; FOREBRAIN; GENOTYPE; HABITUATION; HIPPOCAMPUS; LEARNING; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR;

ANALYSIS OF VARIANCE; ANIMALS; ASSOCIATION LEARNING; CEREBRAL CORTEX; EXPLORATORY BEHAVIOR; HABITUATION, PSYCHOPHYSIOLOGIC; HIPPOCAMPUS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; NEURAL INHIBITION; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; SEROTONIN; STATISTICS, NONPARAMETRIC;

EID: 34848840933     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2007.07.013     Document Type: Article

References (35)

1. Alves R., Barbosa de Carvalho J.G., and Benedito M.A. High and low rearing subgroups of rats selected in the open field differ in the activity of K(+)-stimulated p-nitrophenylphosphatase in the hippocampus. Brain Research 1058 (2005) 178-182
2. Barros D.M., Carlis V., Maidana M., Silva E.S., Baisch A.L., Ramirez M.R., et al. Interactions between anandamide-induced anterograde amnesia and post-training memory modulatory systems. Brain Research 1016 (2004) 66-71
3. Compton D.R., Aceto M.D., Lowe J., and Martin B.R. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of Δ9-tetrahydrocannabinol-induced responses and apparent agonist activity. Journal of Pharmacology and Experimental Therapeutics 277 (1996) 586-594
4. Deacon R.M., Croucher A., and Rawlins J.N. Hippocampal cytotoxic lesion effects on species-typical behaviours in mice. Behavioural Brain Research 132 (2002) 203-213
5. Degroot A., Salhoff C., Davis R.J., and Nomikos G.G. Genetic deletion of CB1 receptors improves non-associative learning. Behavioural Brain Research 162 (2005) 161-164
6. Degroot A., Kofalvi A., Wade M.R., Davis R.J., Rodrigues R.J., Rebola N., et al. CB1 receptor antagonism increases hippocampal acetylcholine release: Site and mechanism of action. Molecular Pharmacology 70 (2006) 1236-1245
7. Del Godino M.C., Torres M., and Sanchez-Prieto J. CB1 receptors diminish both Ca(2+) influx and glutamate release through two different mechanisms active in distinct populations of cerebrocortical nerve terminals. Journal of Neurochemistry 101 (2007) 1471-1482
8. Deshmukh S., Onozuka K., Bender K.J., Bender V.A., Lutz B., Mackie K., et al. Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex. Neuroscience 145 (2007) 279-287
9. Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.K., Zimmer A.M., et al. Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice: Evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain. Journal of Neurochemistry 75 (2000) 2434-2444
10. Fride E. Endocannabinoids in the central nervous system: From neuronal networks to behavior. Current Drug Targets. CNS and Neurological Disorders 4 (2005) 633-642
11. Gerhardt P., Hasenöhrl R.U., Hock F.J., and Huston J.P. Mnemogenic effects of injecting RA-octil, a CE-inhibitor derivate, systemically or into the basal forebrain. Psychopharmacology 111 (1993) 442-448
12. Graeff F.G. On serotonin and experimental anxiety. Psychopharmacology 163 (2002) 467-476
13. Haller J., Bakos N., Szirmay M., Ledent C., and Freund T.F. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. European Journal of Neurology 16 (2002) 1395-1398
14. Hungund B.L., Szakall I., Adam A., Basavarajappa B.S., and Vadasz C. Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. Journal of Neurochemistry 84 (2003) 698-704
15. Huston J.P., Wagner U., and Hasenöhrl R.U. The tuberomammillary nucleus projections in the control of learning, memory and reinforcement processes: Evidence for an inhibitory role. Behavioural Brain Research 83 (1997) 97-105
16. Izquierdo I. The role of an endogenous amnesic mechanism mediated by brain beta-endorphin in memory modulation. Brazilian Journal of Medical and Biological Research 15 (1982) 119-134
17. Izquierdo I., Medina J.H., Vianna M.R., Izquierdo L.A., and Barros D.M. Separate mechanisms for short- and long-term memory. Behavioural Brain Research 103 (1999) 1-11
18. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.-F., Beslot F., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283 (1999) 401-404
19. Lichtman A.H. SR141716A enhances spatial memory as assessed in a radial-arm maze task in rats. European Journal of Pharmacology 404 (2000) 175-179
20. Lichtman A.H., Varvel S.A., and Martin B.R. Endocannabinoids in cognition and dependence. Prostaglandins, Leukotrienes, and Essential Fatty Acids 66 (2002) 269-285
21. Marsicano G., and Lutz B. Neuromodulatory functions of the endocannabinoid system. Journal of Endocrinological Investigation 29 3 Suppl. (2006) 27-46
22. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418 (2002) 530-534
23. Pacher P., Batkai S., and Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Reviews 58 (2006) 389-462
24. Rinaldi-Carmona M., Barth F., Heaulme M., Alonso R., Shire D., Congy C., et al. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sciences 56 (1995) 1941-1947
25. Rolls E.T. Memory systems in the brain. Annual Review of Psychology 51 (2000) 599-630
26. Rubino T., Vigano D., Zagato E., Sala M., and Parolaro D. In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: Behavioral and cellular responses after acute and chronic treatments. Synapse 35 (2000) 8-14
27. Storey J.D., Robertson D.A., Beattie J.E., Reid I.C., Mitchell S.N., and Balfour D.J. Behavioural and neurochemical responses evoked by repeated exposure to an elevated open platform. Behavioral Brain Research 166 (2006) 220-229
28. Thiemann, G., van der Stelt, M., Petrosino, S., Molleman, A., Di Marzo, V., Hasenohrl, R. U. (in preparation). The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-AG, in amphetamine-induced behavioural sensitization. Behavioural Brain Research.
29. Thiemann, G., Ledent, C., Molleman, A., Hasenohrl, R. U. (in preparation). Differential modulation of anxiety by acute and chronic blockade of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain. Neuropsychopharmacology.
30. Tzavara E.T., Davis R.J., Perry K.W., Li X., Salhoff C., Bymaster F.P., et al. The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: Implications for therapeutic actions. British Journal of Pharmacology 138 (2003) 544-553
31. Vanderwolf C.H. Hippocampal electrical activity and voluntary movement in the rat. Electroencephalography and Clinical Neurophysiology 26 (1969) 407-418
32. Varvel S.A., and Lichtman A.H. Evaluation of CB1 receptor knockout mice in the Morris water maze. The Journal of Pharmacology and Experimental Therapeutics 301 (2002) 915-924
33. Vila J.L., Philpot R.M., and Kirstein C.L. Grid crossing: Inability to compare activity levels between adolescent and adult rats. Annals of the New York Academy of Sciences 1021 (2004) 418-421
34. Weiler H.T., Hasenöhrl R.U., van Landeghem A.A., van Landeghem M., Brankack J., Huston J.P., et al. Differential modulation of hippocampal signal transfer by tuberomammillary nucleus stimulation in freely moving rats dependent on behavioral state. Synapse 28 (1998) 294-301
35. Witkin J.M., Tzavara E.T., and Nomikos G.G. A role for cannabinoid CB1 receptors in mood and anxiety disorders. Behavioural Pharmacology 16 (2005) 315-331